BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.01 -0.01 (-50.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Receivables - Other (2018 - 2019)

Updated

BioXcel Therapeutics (BTAIQ) posted Receivables - Other of $46,000 for Q2 2019, down 34.3% from $70,000 a year earlier.

Analysis

BioXcel Therapeutics (BTAIQ) Receivables - Other (2018 - 2019) Analysis & Trends

At the end of FY2018, BioXcel Therapeutics' Receivables - Other came in at $115,000.

  • The Q2 2019 figure stands as the lowest quarterly Receivables - Other since Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 BioXcel Therapeutics 409,050.01 -94.20 Mn 160,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 46,000.00
Dec 31, 2018 115,000.00
Sep 30, 2018 49,000.00
Jun 30, 2018 70,000.00
Mar 31, 2018 44,000.00
API Access

BioXcel Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY